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Objective: More than 900,000 cases of fatal and nonfatal venous thromboembolism (VTE), comprising deep venous thrombosis (DVT) and pulmonary embolus (PE), occur per year in the United States. Several clinical guidelines have recognized the role of thrombolytic therapy in management of acute VTE. However, there is no consensus on thrombolysis in patients with concomitant submassive PE and DVT.
Methods: We evaluated our experience with management of simultaneous diagnosis of DVT and PE. Only those cases with an acute presentation of both DVT and submassive PE were reviewed.
Results: In the past 1 year, we managed four cases with bilateral extensive PE and significant coincident DVT. There was no sex-or race-based predisposition for incidence of concurrent PE and DVT. The mean age was 49 (range, 19-73) years. There were no factor V Leiden deficiencies. All patients had some combination of known risk factors for VTE, including older age, recent travel, immobilization after surgery, sedentary lifestyle, chronic lung disease, female sex, oral contraceptive use, prior history of DVT, and obesity. All patients underwent simultaneous catheter-directed thrombolytic therapy for infusion of tissue plasminogen activator into pulmonary arteries and peripheral veins (external iliac vein and innominate). Concomitant procedures included inferior vena cava filter placement in all and mechanical venous thrombectomy for cases with lower limb DVT. Median total duration of thrombolytic treatment was 30 hours, and total tissue plasminogen activator dose was 26. There were no major bleeding or pulmonary complications. Median intensive care unit stay was 2 days and hospital stay was 5 days. During a median follow-up of 6 months, no recurrence of events was reported.
Conclusions: Catheter-directed infusion of thrombolytic therapy is a feasible option for simultaneous management of concurrent acute DVT and PE. Further studies are required to assess the outcomes and associated factors to identify the target population for this approach. Objective: Primary leiomyosarcoma of the inferior vena cava (IVC) is a rare soft tissue sarcoma (Fig 1) . Techniques for caval reconstruction after tumor resection vary widely. Our single-center experience serves as one of the largest reviews of caval reconstruction Fig 1. Coronal cut of a computed tomography scan depicting a suprarenal inferior vena cava (IVC) leiomyosarcoma in a 61-year-old woman who presented with bilateral lower extremity swelling and back pain.
